Many Locations
Berlin, 13342, Germany
NCT Number: NCT03484260
We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resulting in overestimation of the cardiovascular risk associated with testosterone when compared to a healthier population not taking testosterone
Looking for future studies?
Notify Me18 year and older
Male
Observational
Berlin, 13342, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Men used testosterone product following prescription
Time frame: Retrospectively from 01 January 2001 to 31 March 2016
Bayer
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT03887936
Diabetes Mellitus, Diabetes Mellitus, Type 2
Houston, Texas, United States
View Trial DetailsNCT07097259
Endocrine System Diseases, Genital Diseases
San Antonio, Texas, United States
View Trial DetailsNCT04456296
Endocrine System Diseases, Eunuchism
Birmingham, Alabama, United States
View Trial Details